Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine-Reference-Cited by-同舟云学术

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine

Published:2012-07 Issue:10 Volume:48 Page:1495-1502
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Krajewski Katherine M.,Fougeray Ronan,Bellmunt Joaquim,Pons Francesc,Schutz Fabio A.B.,Rosenberg Jonathan E.,Salhi Yacine,Choueiri Toni K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. European Medicines Agency. Committee for medicinal products for human use: summary of positive opinion for Javior [online]. Available from: http://www.ema.europa.eu/pdfs/human/opinion/Javlor_37089509en.pdf.

2. Vinflunine;Frampton;Drugs,2010

3. Phase III trial of vinflunine and best supportive care compared with best supportive care alone after a platinum containing-regimen in patients with advanced transitional cell carcinoma of the urothelial tract;Bellmunt;J Clin Oncol,2009

4. We should desist using RECIST, at least in GIST;Benjamin;J Clin Oncol,2007

5. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria;Choi;J Clin Oncol,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today’s impact, tomorrow’s potential;Expert Review of Medical Devices;2023-12-12

2. Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis;Cancer Treatment Reviews;2018-12

3. CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?;European Radiology;2018-06-06

4. Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma;Targeted Oncology;2018-05-21

5. The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy;Molecular and Clinical Oncology;2017-10-13